Molina Healthcare (MOH) Financials

$348.92 +3.92 (+1.14%)

As of 04/14/2025 03:58 PM Eastern

Annual Income Statements for Molina Healthcare

This table shows Molina Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	143	52	-512	707	737	673	659	792	1,091	1,179
Consolidated Net Income / (Loss)	143	52	-512	707	737	673	659	792	1,091	1,179
Net Income / (Loss) Continuing Operations	143	52	-512	707	737	673	659	792	1,091	1,179
Total Pre-Tax Income	322	205	-612	999	972	961	875	1,063	1,464	1,589
Total Operating Income	387	306	-555	1,131	1,044	1,078	1,020	1,173	1,573	1,707
Total Gross Profit	13,985	17,297	2,318	3,389	2,924	3,603	4,067	4,799	5,403	6,222
Total Revenue	14,178	17,782	19,883	18,890	16,829	19,423	27,771	31,974	34,072	40,650
Operating Revenue	14,178	17,782	19,883	18,890	16,829	19,423	27,771	31,974	34,072	40,650
Total Cost of Revenue	193	485	17,565	15,501	13,905	15,820	23,704	27,175	28,669	34,428
Operating Cost of Revenue	193	485	17,565	15,501	13,905	15,820	23,704	27,175	28,669	34,428
Total Operating Expenses	13,598	16,991	2,873	2,258	1,880	2,525	3,047	3,626	3,830	4,515
Selling, General & Admin Expense	1,146	1,393	1,594	1,394	1,302	1,511	2,129	2,369	2,590	2,843
Depreciation Expense	104	139	137	99	89	88	131	176	171	186
Other Operating Expenses / (Income)	12,348	15,459	438	765	489	926	787	873	1,069	1,486
Impairment Charge	0.00	0.00	470	-	-	0.00	0.00	208	0.00	0.00
Total Other Income / (Expense), net	-65	-101	-57	-132	-72	-117	-145	-110	-109	-118
Interest Expense	66	101	118	115	87	102	120	110	109	118
Income Tax Expense	179	153	-100	292	235	288	216	271	373	410
Basic Earnings per Share	$2.75	$0.93	($9.07)	$11.57	$11.85	$11.40	$11.40	$13.72	$18.91	$20.52
Weighted Average Basic Shares Outstanding	52M	55M	56.40M	61.10M	62.20M	59M	57.80M	57.80M	57.70M	57.40M
Diluted Earnings per Share	$2.58	$0.92	($9.07)	$10.61	$11.47	$11.23	$11.25	$13.55	$18.77	$20.42
Weighted Average Diluted Shares Outstanding	56M	56.20M	56.40M	66.60M	64.20M	59.90M	58.60M	58.50M	58.10M	57.70M
Weighted Average Basic & Diluted Shares Outstanding	52M	55.90M	56.40M	61.10M	60.80M	58M	58.40M	57.90M	58.40M	55.50M

This table shows Molina Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	230	56	321	309	245	216	301	301	326	251
Consolidated Net Income / (Loss)	230	56	321	309	245	216	301	301	326	251
Net Income / (Loss) Continuing Operations	230	56	321	309	245	216	301	301	326	251
Total Pre-Tax Income	307	78	427	416	332	289	399	406	438	346
Total Operating Income	335	105	455	443	359	316	426	434	467	380
Total Gross Profit	1,179	1,231	1,278	1,289	1,242	1,594	1,517	1,512	1,697	1,496
Total Revenue	7,927	8,223	8,149	8,327	8,548	9,048	9,931	9,880	10,340	10,499
Operating Revenue	7,927	8,223	8,149	8,327	8,548	9,048	9,931	9,880	10,340	10,499
Total Cost of Revenue	6,748	6,992	6,871	7,038	7,306	7,454	8,414	8,368	8,643	9,003
Operating Cost of Revenue	6,748	6,992	6,871	7,038	7,306	7,454	8,414	8,368	8,643	9,003
Total Operating Expenses	844	1,126	823	846	883	1,278	1,091	1,078	1,231	1,115
Selling, General & Admin Expense	576	644	607	635	608	740	749	734	676	684
Depreciation Expense	45	47	44	42	42	43	45	46	47	48
Other Operating Expenses / (Income)	223	227	172	169	233	495	297	298	508	383
Total Other Income / (Expense), net	-28	-27	-28	-27	-27	-27	-27	-28	-29	-34
Interest Expense	28	27	28	27	27	27	27	28	29	34
Income Tax Expense	77	22	106	107	87	73	98	105	112	95
Basic Earnings per Share	$4.00	$0.98	$5.58	$5.37	$4.24	$3.72	$5.21	$5.18	$5.67	$4.46
Weighted Average Basic Shares Outstanding	58.40M	57.80M	58.30M	58.30M	58.30M	57.70M	58.60M	58.60M	57.20M	57.40M
Diluted Earnings per Share	$3.95	$0.96	$5.52	$5.35	$4.21	$3.69	$5.17	$5.17	$5.65	$4.43
Weighted Average Diluted Shares Outstanding	58.40M	58.50M	58.30M	58.30M	58.30M	58.10M	58.60M	58.60M	57.20M	57.70M
Weighted Average Basic & Diluted Shares Outstanding	58.40M	57.90M	58.30M	58.30M	58.30M	58.40M	58.60M	58.60M	57.20M	55.50M

This table details how cash moves in and out of Molina Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	790	486	378	-364	-418	1,715	283	-458	860	-167
Net Cash From Operating Activities	1,125	673	804	-314	434	1,898	2,119	773	1,662	644
Net Cash From Continuing Operating Activities	1,125	673	804	-314	434	1,898	2,119	773	1,662	644
Net Income / (Loss) Continuing Operations	143	52	-512	707	737	673	659	792	1,091	1,179
Consolidated Net Income / (Loss)	143	52	-512	707	737	673	659	792	1,091	1,179
Depreciation Expense	126	182	178	127	89	88	131	176	171	186
Non-Cash Adjustments To Reconcile Net Income	23	26	931	81	24	72	1,143	311	115	-337
Changes in Operating Assets and Liabilities, net	803	382	175	-1,229	-416	1,065	186	-506	285	-384
Net Cash From Investing Activities	-1,420	-206	-1,062	1,143	-293	-400	-1,653	-790	-744	-464
Net Cash From Continuing Investing Activities	-1,420	-206	-1,062	1,143	-293	-400	-1,653	-790	-744	-464
Purchase of Property, Plant & Equipment	-132	-176	-86	-30	-57	-74	-77	-91	-84	-100
Acquisitions	-450	-48	-	0.00	0.00	-755	-129	-134	-3.00	-344
Purchase of Investments	-1,929	-1,929	-2,697	-1,444	-2,536	-670	-2,713	-1,913	-1,433	-1,132
Sale and/or Maturity of Investments	1,126	1,966	1,759	2,445	2,302	1,097	1,329	1,398	772	1,111
Other Investing Activities, net	-35	-19	-38	-18	-2.00	2.00	-63	-50	4.00	1.00
Net Cash From Financing Activities	1,085	19	636	-1,193	-559	217	-183	-441	-58	-347
Net Cash From Continuing Financing Activities	1,085	19	636	-1,193	-559	217	-183	-441	-58	-347
Repayment of Debt	0.00	0.00	11	-662	-211	-948	-722	33	2.00	-330
Repurchase of Common Equity	-	0.00	0.00	-549	-561	-636	-128	-400	0.00	-1,000
Issuance of Debt	694	19	625	18	220	1,809	740	0.00	0.00	1,040
Other Financing Activities, net	-	0.00	0.00	0.00	-7.00	-8.00	-73	-74	-60	-57
Cash Interest Paid	38	66	78	93	78	112	127	108	108	121
Cash Income Taxes Paid	197	153	7.00	240	239	321	235	340	405	379

This table details how cash moves in and out of Molina Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-83	-247	549	360	663	-712	-336	-154	461	-138
Net Cash From Operating Activities	254	-212	916	487	949	-690	214	-219	873	-224
Net Cash From Continuing Operating Activities	254	-212	916	487	949	-690	214	-219	873	-224
Net Income / (Loss) Continuing Operations	230	56	321	309	245	216	301	301	326	251
Consolidated Net Income / (Loss)	230	56	321	309	245	216	301	301	326	251
Depreciation Expense	45	47	44	42	42	43	45	46	47	48
Non-Cash Adjustments To Reconcile Net Income	-224	231	295	270	-477	27	219	-194	73	-435
Changes in Operating Assets and Liabilities, net	203	-546	256	-134	1,139	-976	-351	-372	427	-88
Net Cash From Investing Activities	-347	148	-302	-137	-280	-25	-488	53	-48	19
Net Cash From Continuing Investing Activities	-347	148	-302	-137	-280	-25	-488	53	-48	19
Purchase of Property, Plant & Equipment	-31	-10	-32	-31	-26	5.00	-27	-27	-35	-11
Purchase of Investments	-351	-149	-646	-278	-371	-138	-380	-214	-395	-143
Sale and/or Maturity of Investments	203	316	371	175	124	102	211	295	365	240
Other Investing Activities, net	-34	-9.00	5.00	-3.00	-4.00	6.00	3.00	-1.00	66	-67
Net Cash From Financing Activities	10	-183	-65	10	-6.00	3.00	-62	12	-364	67
Net Cash From Continuing Financing Activities	10	-183	-65	10	-6.00	3.00	-62	12	-364	67
Repayment of Debt	10	18	-7.00	11	-5.00	3.00	-6.00	12	-163	-173
Repurchase of Common Equity	-	-200	-	-	-	-	-	-	-	-500
Issuance of Debt	-	-	-	-	-	-	-	-	-	740

This table presents Molina Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	6,576	7,449	8,471	7,154	6,787	9,532	12,209	12,314	14,892	15,630
Total Current Assets	5,306	5,988	7,511	6,462	5,967	7,876	10,064	10,084	12,542	12,773
Cash & Equivalents	2,329	2,819	3,186	2,826	2,452	4,154	4,438	4,006	4,848	4,662
Short-Term Investments	1,801	1,758	2,524	1,681	1,946	1,875	3,202	3,499	4,259	4,325
Accounts Receivable	597	974	871	1,330	1,406	1,672	2,177	2,302	3,104	3,299
Prepaid Expenses	192	131	239	149	163	175	247	277	331	487
Plant, Property, & Equipment, net	393	454	342	241	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	877	1,007	618	451	820	1,656	2,145	2,230	2,350	2,857
Long-Term Investments	109	110	119	120	79	136	212	238	261	286
Goodwill	519	620	255	190	172	941	1,252	1,390	1,449	1,938
Noncurrent Deferred & Refundable Income Taxes	18	10	103	117	79	69	106	220	227	207
Other Noncurrent Operating Assets	109	127	141	24	490	510	575	382	413	426
Total Liabilities & Shareholders' Equity	6,576	7,449	8,471	7,154	6,787	9,532	12,209	12,314	14,892	15,630
Total Liabilities	5,019	5,800	7,134	5,507	4,827	7,436	9,579	9,350	10,677	11,134
Total Current Liabilities	3,822	4,570	5,557	4,246	3,269	4,965	7,047	6,855	8,168	7,896
Accounts Payable	362	385	366	390	502	641	842	889	1,252	1,331
Current Deferred Revenue	223	315	282	211	249	375	370	359	418	51
Other Current Liabilities	2,788	3,398	4,256	3,404	2,518	3,949	5,835	5,607	6,498	6,514
Total Noncurrent Liabilities	1,197	1,230	1,577	1,261	1,558	2,471	2,532	2,495	2,509	3,238
Long-Term Debt	962	975	1,318	1,020	1,237	2,127	2,173	2,176	2,180	2,923
Other Noncurrent Operating Liabilities	37	42	61	44	321	344	359	319	329	315
Total Equity & Noncontrolling Interests	1,557	1,649	1,337	1,647	1,960	2,096	2,630	2,964	4,215	4,496
Total Preferred & Common Equity	1,557	1,649	1,337	1,647	1,960	2,096	2,630	2,964	4,215	4,496
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,557	1,649	1,337	1,647	1,960	2,096	2,630	2,964	4,215	4,496
Common Stock	803	841	1,044	643	175	199	236	328	410	462
Retained Earnings	758	810	298	1,012	1,781	1,860	2,399	2,796	3,887	4,091
Accumulated Other Comprehensive Income / (Loss)	-4.00	-2.00	-5.00	-8.00	4.00	37	-5.00	-160	-82	-57

This table presents Molina Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	12,793	12,314	13,371	13,661	14,870	14,892	15,513	15,185	15,758	15,630
Total Current Assets	10,492	10,084	11,159	11,441	12,468	12,542	12,668	12,331	12,881	12,773
Cash & Equivalents	4,242	4,006	4,554	4,910	5,565	4,848	4,513	4,354	4,732	4,662
Short-Term Investments	3,639	3,499	3,810	3,886	4,111	4,259	4,424	4,347	4,482	4,325
Accounts Receivable	2,220	2,302	2,536	2,385	2,460	3,104	3,350	3,231	3,259	3,299
Prepaid Expenses	391	277	259	260	332	331	381	399	408	487
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	2,301	2,230	2,212	2,220	2,402	2,350	2,845	2,854	2,877	2,857
Long-Term Investments	242	238	242	249	261	261	261	268	289	286
Goodwill	1,263	1,390	1,369	1,348	1,471	1,449	1,927	1,913	1,923	1,938
Noncurrent Deferred & Refundable Income Taxes	198	220	208	220	255	227	228	232	227	207
Other Noncurrent Operating Assets	598	382	393	403	415	413	429	441	438	426
Total Liabilities & Shareholders' Equity	12,793	12,314	13,371	13,661	14,870	14,892	15,513	15,185	15,758	15,630
Total Liabilities	9,752	9,350	10,083	10,040	10,991	10,677	11,020	10,342	10,988	11,134
Total Current Liabilities	7,242	6,855	7,614	7,537	8,492	8,168	8,514	7,836	8,337	7,896
Accounts Payable	818	889	787	857	1,090	1,252	1,114	973	1,215	1,331
Current Deferred Revenue	663	359	654	414	691	418	328	13	364	51
Other Current Liabilities	5,761	5,607	6,173	6,266	6,711	6,498	7,072	6,850	6,758	6,514
Total Noncurrent Liabilities	2,510	2,495	2,469	2,503	2,499	2,509	2,506	2,506	2,651	3,238
Long-Term Debt	2,175	2,176	2,177	2,178	2,179	2,180	2,180	2,181	2,332	2,923
Other Noncurrent Operating Liabilities	335	319	292	325	320	329	326	325	319	315
Total Equity & Noncontrolling Interests	3,041	2,964	3,288	3,621	3,879	4,215	4,493	4,843	4,770	4,496
Total Preferred & Common Equity	3,041	2,964	3,288	3,621	3,879	4,215	4,493	4,843	4,770	4,496
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,041	2,964	3,288	3,621	3,879	4,215	4,493	4,843	4,770	4,496
Common Stock	289	328	296	341	373	410	390	439	453	462
Retained Earnings	2,937	2,796	3,117	3,426	3,671	3,887	4,188	4,489	4,326	4,091
Accumulated Other Comprehensive Income / (Loss)	-185	-160	-125	-146	-165	-82	-85	-85	-9.00	-57

This table displays calculated financial ratios and metrics derived from Molina Healthcare's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	46.66%	25.42%	11.82%	-4.99%	-10.91%	15.41%	42.98%	15.13%	6.56%	19.31%
EBITDA Growth	54.11%	-4.60%	-154.72%	536.97%	-7.49%	0.26%	-2.17%	19.80%	29.28%	8.54%
EBIT Growth	102.08%	-21.13%	-261.44%	325.51%	-4.94%	0.38%	-6.40%	17.89%	34.10%	8.52%
NOPAT Growth	93.90%	-54.84%	-600.52%	306.03%	-1.10%	-4.63%	1.76%	13.77%	34.13%	8.05%
Net Income Growth	130.65%	-63.64%	-1,084.62%	238.09%	4.24%	-8.68%	-2.08%	20.18%	37.75%	8.07%
EPS Growth	100.00%	-64.34%	-1,085.87%	216.98%	8.11%	-2.09%	0.18%	20.44%	38.52%	8.79%
Operating Cash Flow Growth	6.13%	-40.18%	19.47%	-139.05%	238.22%	337.33%	11.64%	-63.52%	115.01%	-61.25%
Free Cash Flow Firm Growth	-41.76%	-17.48%	78.69%	-123.87%	424.09%	157.82%	32.34%	-77.18%	260.37%	-90.43%
Invested Capital Growth	-40.63%	-29.82%	-78.89%	38.92%	15.90%	-51.72%	-57.00%	14.63%	-14.21%	37.64%
Revenue Q/Q Growth	8.16%	3.87%	2.13%	-1.49%	-2.26%	5.21%	8.49%	2.61%	2.48%	3.70%
EBITDA Q/Q Growth	-3.52%	-11.58%	-28,500.00%	72.36%	-3.37%	-10.64%	8.27%	-5.20%	13.47%	3.78%
EBIT Q/Q Growth	-4.79%	-21.13%	-127.65%	102.18%	-3.46%	-11.64%	8.15%	-6.83%	15.49%	3.90%
NOPAT Q/Q Growth	0.15%	-54.72%	-90.07%	137.41%	-3.70%	-13.83%	11.81%	-7.25%	15.83%	3.23%
Net Income Q/Q Growth	-2.44%	-59.69%	-72.39%	189.75%	-4.29%	-16.60%	11.69%	-5.60%	17.19%	3.06%
EPS Q/Q Growth	-6.52%	-60.00%	-71.78%	263.36%	-3.21%	-15.82%	11.72%	-5.44%	17.02%	3.76%
Operating Cash Flow Q/Q Growth	0.02%	-21.01%	-19.36%	8.72%	57.82%	198.90%	-24.88%	-51.14%	-22.34%	261.80%
Free Cash Flow Firm Q/Q Growth	-39.21%	55.31%	-18.01%	60.64%	-5.58%	189.08%	-22.13%	-60.53%	-22.27%	158.76%
Invested Capital Q/Q Growth	16.33%	-1.90%	-2.21%	8.86%	10.49%	-86.02%	-10.27%	10.46%	23.36%	22.78%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	98.64%	97.27%	11.66%	17.94%	17.37%	18.55%	14.64%	15.01%	15.86%	15.31%
EBITDA Margin	3.84%	2.92%	-1.43%	6.57%	6.82%	5.93%	4.05%	4.22%	5.12%	4.66%
Operating Margin	2.73%	1.72%	-2.79%	5.99%	6.20%	5.55%	3.67%	3.67%	4.62%	4.20%
EBIT Margin	2.74%	1.72%	-2.48%	5.90%	6.29%	5.47%	3.58%	3.67%	4.62%	4.20%
Profit (Net Income) Margin	1.01%	0.29%	-2.58%	3.74%	4.38%	3.47%	2.37%	2.48%	3.20%	2.90%
Tax Burden Percent	44.41%	25.37%	83.66%	70.77%	75.82%	70.03%	75.31%	74.51%	74.52%	74.20%
Interest Burden Percent	82.99%	66.99%	123.89%	89.68%	91.78%	90.40%	87.94%	90.62%	93.07%	93.09%
Effective Tax Rate	55.59%	74.63%	0.00%	29.23%	24.18%	29.97%	24.69%	25.49%	25.48%	25.80%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	11.14%	3.24%	-34.29%	47.39%	40.87%	33.19%	27.89%	28.32%	30.39%	27.07%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	7.05%	4.36%	-6.21%	14.26%	15.19%	13.03%	9.15%	9.57%	11.56%	11.19%
Return on Assets (ROA)	2.60%	0.74%	-6.43%	9.05%	10.57%	8.25%	6.06%	6.46%	8.02%	7.73%
Return on Common Equity (ROCE)	11.14%	3.24%	-34.29%	47.39%	40.87%	33.19%	27.89%	28.32%	30.39%	27.07%
Return on Equity Simple (ROE_SIMPLE)	9.18%	3.15%	-38.29%	42.93%	37.60%	32.11%	25.06%	26.72%	25.88%	26.22%
Net Operating Profit after Tax (NOPAT)	172	78	-389	800	792	755	768	874	1,172	1,267
NOPAT Margin	1.21%	0.44%	-1.95%	4.24%	4.70%	3.89%	2.77%	2.73%	3.44%	3.12%
Net Nonoperating Expense Percent (NNEP)	-1.31%	-0.90%	-3.59%	-2.67%	-1.70%	-2.25%	-2.25%	-1.46%	-1.27%	-1.29%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	17.00%	18.33%	17.07%
Cost of Revenue to Revenue	1.36%	2.73%	88.34%	82.06%	82.63%	81.45%	85.36%	84.99%	84.14%	84.69%
SG&A Expenses to Revenue	8.08%	7.83%	8.02%	7.38%	7.74%	7.78%	7.67%	7.41%	7.60%	6.99%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	95.91%	95.55%	14.45%	11.95%	11.17%	13.00%	10.97%	11.34%	11.24%	11.11%
Earnings before Interest and Taxes (EBIT)	388	306	-494	1,114	1,059	1,063	995	1,173	1,573	1,707
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	544	519	-284	1,241	1,148	1,151	1,126	1,349	1,744	1,893
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.17	1.87	3.27	4.40	4.34	6.02	7.06	6.51	5.00	3.70
Price to Tangible Book Value (P/TBV)	3.68	3.47	4.05	4.98	4.76	10.92	13.48	12.25	7.62	6.51
Price to Revenue (P/Rev)	0.24	0.17	0.22	0.38	0.51	0.65	0.67	0.60	0.62	0.41
Price to Earnings (P/E)	23.58	59.29	0.00	10.26	11.54	18.74	28.19	24.35	19.31	14.12
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.24%	1.69%	0.00%	9.75%	8.66%	5.34%	3.55%	4.11%	5.18%	7.08%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.05	0.00	0.03	0.22	0.31	0.44	0.46	0.43	0.41	0.25
Enterprise Value to EBITDA (EV/EBITDA)	1.36	0.08	0.00	3.29	4.59	7.45	11.45	10.17	7.96	5.44
Enterprise Value to EBIT (EV/EBIT)	1.91	0.13	0.00	3.66	4.97	8.07	12.96	11.69	8.82	6.03
Enterprise Value to NOPAT (EV/NOPAT)	4.32	0.53	0.00	5.10	6.65	11.36	16.79	15.70	11.84	8.13
Enterprise Value to Operating Cash Flow (EV/OCF)	0.66	0.06	0.68	0.00	12.14	4.52	6.09	17.75	8.35	15.99
Enterprise Value to Free Cash Flow (EV/FCFF)	1.54	0.10	0.77	0.00	9.58	6.05	6.88	32.05	9.00	69.79
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.03	1.00	1.62	0.89	0.63	1.01	0.83	0.73	0.52	0.65
Long-Term Debt to Equity	0.75	0.71	1.13	0.74	0.63	1.01	0.83	0.73	0.52	0.65
Financial Leverage	-1.72	-1.77	-2.30	-2.35	-1.78	-1.79	-2.06	-2.01	-1.78	-1.55
Leverage Ratio	4.29	4.37	5.33	5.24	3.87	4.02	4.60	4.38	3.79	3.50
Compound Leverage Factor	3.56	2.93	6.61	4.70	3.55	3.64	4.05	3.97	3.53	3.26
Debt to Total Capital	50.82%	49.94%	61.87%	46.96%	38.69%	50.37%	45.24%	42.33%	34.09%	39.40%
Short-Term Debt to Total Capital	14.18%	14.33%	18.63%	7.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	36.64%	35.61%	43.24%	39.19%	38.69%	50.37%	45.24%	42.33%	34.09%	39.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	49.18%	50.06%	38.13%	53.04%	61.31%	49.63%	54.76%	57.67%	65.91%	60.60%
Debt to EBITDA	2.96	3.17	-7.64	1.17	1.08	1.85	1.93	1.61	1.25	1.54
Net Debt to EBITDA	-4.83	-5.86	13.48	-2.55	-2.82	-3.51	-5.04	-4.13	-4.12	-3.35
Long-Term Debt to EBITDA	2.13	2.26	-5.34	0.98	1.08	1.85	1.93	1.61	1.25	1.54
Debt to NOPAT	9.36	21.19	-5.58	1.82	1.56	2.82	2.83	2.49	1.86	2.31
Net Debt to NOPAT	-15.30	-39.19	9.86	-3.96	-4.09	-5.35	-7.39	-6.37	-6.13	-5.01
Long-Term Debt to NOPAT	6.75	15.11	-3.90	1.52	1.56	2.82	2.83	2.49	1.86	2.31
Altman Z-Score	3.19	3.22	2.85	4.51	4.90	4.06	4.28	4.78	4.54	4.60
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.39	1.31	1.35	1.52	1.83	1.59	1.43	1.47	1.54	1.62
Quick Ratio	1.24	1.21	1.18	1.37	1.78	1.55	1.39	1.43	1.50	1.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	482	398	711	-170	550	1,417	1,875	428	1,542	148
Operating Cash Flow to CapEx	852.27%	382.39%	934.88%	-1,046.67%	761.40%	2,564.86%	2,751.95%	849.45%	1,978.57%	644.00%
Free Cash Flow to Firm to Interest Expense	7.30	3.94	6.02	-1.47	6.32	13.89	15.63	3.89	14.15	1.25
Operating Cash Flow to Interest Expense	17.05	6.66	6.81	-2.73	4.99	18.61	17.66	7.03	15.25	5.46
Operating Cash Flow Less CapEx to Interest Expense	15.05	4.92	6.08	-2.99	4.33	17.88	17.02	6.20	14.48	4.61
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.58	2.54	2.50	2.42	2.41	2.38	2.55	2.61	2.50	2.66
Accounts Receivable Turnover	23.77	22.64	21.55	17.16	12.30	12.62	14.43	14.28	12.61	12.70
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	38.63	41.99	49.96	64.80	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.64	1.30	46.78	41.01	31.18	27.68	31.97	31.40	26.78	26.66
Days Sales Outstanding (DSO)	15.36	16.12	16.93	21.26	29.67	28.92	25.29	25.57	28.96	28.75
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	571.14	281.09	7.80	8.90	11.71	13.19	11.42	11.62	13.63	13.69
Cash Conversion Cycle (CCC)	-555.78	-264.96	9.13	12.36	17.96	15.74	13.88	13.94	15.33	15.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-1,073	-1,393	-2,492	-1,522	-1,280	-1,942	-3,049	-2,603	-2,973	-1,854
Invested Capital Turnover	-15.44	-14.42	-10.24	-9.41	-12.01	-12.06	-11.13	-11.31	-12.22	-16.84
Increase / (Decrease) in Invested Capital	-310	-320	-1,099	970	242	-662	-1,107	446	-370	1,119
Enterprise Value (EV)	742	41	549	4,082	5,268	8,574	12,897	13,718	13,876	10,298
Market Capitalization	3,372	3,083	4,378	7,251	8,508	12,612	18,576	19,285	21,064	16,648
Book Value per Share	$27.76	$29.02	$23.42	$26.40	$31.26	$35.35	$45.03	$50.75	$72.30	$78.60
Tangible Book Value per Share	$16.33	$15.65	$18.95	$23.35	$28.52	$19.48	$23.60	$26.95	$47.44	$44.72
Total Capital	3,166	3,294	3,506	3,105	3,197	4,223	4,803	5,140	6,395	7,419
Total Debt	1,609	1,645	2,169	1,458	1,237	2,127	2,173	2,176	2,180	2,923
Total Long-Term Debt	1,160	1,173	1,516	1,217	1,237	2,127	2,173	2,176	2,180	2,923
Net Debt	-2,630	-3,042	-3,829	-3,169	-3,240	-4,038	-5,679	-5,567	-7,188	-6,350
Capital Expenditures (CapEx)	132	176	86	30	57	74	77	91	84	100
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2,197	-2,687	-3,272	-2,050	-1,700	-3,118	-4,623	-4,276	-4,733	-4,110
Debt-free Net Working Capital (DFNWC)	1,933	1,890	2,607	2,457	2,698	2,911	3,017	3,229	4,374	4,877
Net Working Capital (NWC)	1,484	1,418	1,954	2,216	2,698	2,911	3,017	3,229	4,374	4,877
Net Nonoperating Expense (NNE)	29	26	124	93	55	82	109	82	81	88
Net Nonoperating Obligations (NNO)	-2,630	-3,042	-3,829	-3,169	-3,240	-4,038	-5,679	-5,567	-7,188	-6,350
Total Depreciation and Amortization (D&A)	156	213	210	127	89	88	131	176	171	186
Debt-free, Cash-free Net Working Capital to Revenue	-15.50%	-15.11%	-16.46%	-10.85%	-10.10%	-16.05%	-16.65%	-13.37%	-13.89%	-10.11%
Debt-free Net Working Capital to Revenue	13.63%	10.63%	13.11%	13.01%	16.03%	14.99%	10.86%	10.10%	12.84%	12.00%
Net Working Capital to Revenue	10.47%	7.97%	9.83%	11.73%	16.03%	14.99%	10.86%	10.10%	12.84%	12.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.75	$0.93	($9.07)	$11.57	$11.85	$11.40	$11.40	$13.72	$18.91	$20.52
Adjusted Weighted Average Basic Shares Outstanding	52M	55M	56M	61M	62.20M	59M	57.80M	57.80M	57.70M	57.40M
Adjusted Diluted Earnings per Share	$2.58	$0.92	($9.07)	$10.61	$11.47	$11.23	$11.25	$13.55	$18.77	$20.42
Adjusted Weighted Average Diluted Shares Outstanding	56M	56M	56M	67M	64.20M	59.90M	58.60M	58.50M	58.10M	57.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.20M	56.75M	59.73M	62.46M	60.80M	58M	58.40M	57.90M	58.40M	55.50M
Normalized Net Operating Profit after Tax (NOPAT)	271	214	104	800	792	755	768	1,029	1,172	1,267
Normalized NOPAT Margin	1.91%	1.20%	0.52%	4.24%	4.70%	3.89%	2.77%	3.22%	3.44%	3.12%
Pre Tax Income Margin	2.27%	1.15%	-3.08%	5.29%	5.78%	4.95%	3.15%	3.32%	4.30%	3.91%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.88	3.03	-4.19	9.69	12.17	10.42	8.29	10.66	14.43	14.47
NOPAT to Interest Expense	2.60	0.77	-3.29	6.96	9.10	7.40	6.40	7.95	10.75	10.73
EBIT Less CapEx to Interest Expense	3.88	1.29	-4.92	9.43	11.52	9.70	7.65	9.84	13.66	13.62
NOPAT Less CapEx to Interest Expense	0.60	-0.97	-4.02	6.70	8.44	6.68	5.76	7.12	9.98	9.89
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	77.65%	76.12%	94.50%	19.42%	50.51%	0.00%	84.82%

This table displays calculated financial ratios and metrics derived from Molina Healthcare's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.60%	10.99%	4.88%	3.39%	7.83%	10.03%	21.87%	18.65%	20.96%	16.04%
EBITDA Growth	50.20%	-32.74%	21.12%	19.75%	5.53%	136.18%	-5.61%	-1.03%	28.18%	19.22%
EBIT Growth	51.58%	-45.03%	22.31%	22.71%	7.16%	200.95%	-6.37%	-2.03%	30.08%	20.25%
NOPAT Growth	51.68%	-47.89%	22.60%	22.76%	5.56%	213.30%	-6.05%	-2.22%	31.20%	16.72%
Net Income Growth	60.84%	-45.63%	24.42%	24.60%	6.52%	285.71%	-6.23%	-2.59%	33.06%	16.20%
EPS Growth	60.57%	-44.83%	25.74%	25.88%	6.58%	284.38%	-6.34%	-3.36%	34.20%	20.05%
Operating Cash Flow Growth	-44.90%	-135.51%	152.34%	32.34%	273.62%	-225.47%	-76.64%	-144.97%	-8.01%	67.54%
Free Cash Flow Firm Growth	-79.17%	-129.61%	-60.50%	-44.34%	214.76%	263.56%	-167.26%	-303.14%	-191.39%	-239.12%
Invested Capital Growth	-5.14%	14.63%	-3.15%	-4.95%	-33.44%	-14.21%	19.61%	40.08%	38.10%	37.64%
Revenue Q/Q Growth	-1.58%	3.73%	-0.90%	2.18%	2.65%	5.85%	9.76%	-0.51%	4.66%	1.54%
EBITDA Q/Q Growth	-6.17%	-60.00%	228.29%	-2.81%	-17.32%	-10.47%	31.20%	1.91%	7.08%	-16.73%
EBIT Q/Q Growth	-7.20%	-68.66%	333.33%	-2.64%	-18.96%	-11.98%	34.81%	1.88%	7.60%	-18.63%
NOPAT Q/Q Growth	-6.37%	-69.96%	353.74%	-3.80%	-19.49%	-10.85%	36.07%	0.12%	8.03%	-20.69%
Net Income Q/Q Growth	-7.26%	-75.65%	473.21%	-3.74%	-20.71%	-11.84%	39.35%	0.00%	8.31%	-23.01%
EPS Q/Q Growth	-7.06%	-75.70%	475.00%	-3.08%	-21.31%	-12.35%	40.11%	0.00%	9.28%	-21.59%
Operating Cash Flow Q/Q Growth	-30.98%	-183.46%	532.08%	-46.83%	94.87%	-172.71%	131.01%	-202.34%	498.63%	-125.66%
Free Cash Flow Firm Q/Q Growth	-54.62%	-194.31%	218.20%	10.05%	156.59%	-50.99%	-148.60%	-232.36%	-15.44%	25.40%
Invested Capital Q/Q Growth	6.01%	10.46%	-20.67%	-3.34%	-19.50%	23.36%	15.07%	22.97%	-23.44%	22.78%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.87%	14.97%	15.68%	15.48%	14.53%	17.62%	15.28%	15.30%	16.41%	14.25%
EBITDA Margin	4.79%	1.85%	6.12%	5.82%	4.69%	3.97%	4.74%	4.86%	4.97%	4.08%
Operating Margin	4.23%	1.28%	5.58%	5.32%	4.20%	3.49%	4.29%	4.39%	4.52%	3.62%
EBIT Margin	4.23%	1.28%	5.58%	5.32%	4.20%	3.49%	4.29%	4.39%	4.52%	3.62%
Profit (Net Income) Margin	2.90%	0.68%	3.94%	3.71%	2.87%	2.39%	3.03%	3.05%	3.15%	2.39%
Tax Burden Percent	74.92%	71.79%	75.18%	74.28%	73.80%	74.74%	75.44%	74.14%	74.43%	72.54%
Interest Burden Percent	91.64%	74.29%	93.85%	93.91%	92.48%	91.46%	93.66%	93.55%	93.79%	91.05%
Effective Tax Rate	25.08%	28.21%	24.82%	25.72%	26.20%	25.26%	24.56%	25.86%	25.57%	27.46%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	30.19%	28.32%	28.12%	28.40%	26.91%	30.39%	27.53%	25.12%	26.45%	27.07%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	11.05%	3.33%	14.04%	13.23%	10.10%	8.75%	10.65%	11.39%	11.56%	9.64%
Return on Assets (ROA)	7.59%	1.78%	9.91%	9.23%	6.89%	5.98%	7.52%	7.90%	8.07%	6.37%
Return on Common Equity (ROCE)	30.19%	28.32%	28.12%	28.40%	26.91%	30.39%	27.53%	25.12%	26.45%	27.07%
Return on Equity Simple (ROE_SIMPLE)	27.59%	0.00%	26.00%	25.30%	24.00%	0.00%	23.84%	21.95%	23.98%	0.00%
Net Operating Profit after Tax (NOPAT)	251	75	342	329	265	236	321	322	348	276
NOPAT Margin	3.17%	0.92%	4.20%	3.95%	3.10%	2.61%	3.24%	3.26%	3.36%	2.63%
Net Nonoperating Expense Percent (NNEP)	-0.37%	-0.34%	-0.34%	-0.31%	-0.29%	-0.32%	-0.30%	-0.30%	-0.29%	-0.36%
Return On Investment Capital (ROIC_SIMPLE)	-	1.47%	-	-	-	3.69%	-	-	-	3.72%
Cost of Revenue to Revenue	85.13%	85.03%	84.32%	84.52%	85.47%	82.38%	84.72%	84.70%	83.59%	85.75%
SG&A Expenses to Revenue	7.27%	7.83%	7.45%	7.63%	7.11%	8.18%	7.54%	7.43%	6.54%	6.51%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	10.65%	13.69%	10.10%	10.16%	10.33%	14.12%	10.99%	10.91%	11.91%	10.62%
Earnings before Interest and Taxes (EBIT)	335	105	455	443	359	316	426	434	467	380
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	380	152	499	485	401	359	471	480	514	428
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.30	6.51	4.71	4.85	4.93	5.00	5.33	3.60	4.23	3.70
Price to Tangible Book Value (P/TBV)	10.78	12.25	8.07	7.73	7.94	7.62	9.33	5.95	7.09	6.51
Price to Revenue (P/Rev)	0.62	0.60	0.48	0.54	0.58	0.62	0.67	0.47	0.52	0.41
Price to Earnings (P/E)	22.84	24.35	18.11	19.17	20.53	19.31	22.36	16.39	17.65	14.12
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.38%	4.11%	5.52%	5.22%	4.87%	5.18%	4.47%	6.10%	5.67%	7.08%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.42	0.43	0.28	0.33	0.34	0.41	0.47	0.28	0.33	0.25
Enterprise Value to EBITDA (EV/EBITDA)	9.29	10.17	6.31	7.05	7.39	7.96	9.87	6.22	7.14	5.44
Enterprise Value to EBIT (EV/EBIT)	10.50	11.69	7.21	7.99	8.34	8.82	10.97	6.93	7.92	6.03
Enterprise Value to NOPAT (EV/NOPAT)	14.03	15.70	9.67	10.72	11.22	11.84	14.70	9.29	10.61	8.13
Enterprise Value to Operating Cash Flow (EV/OCF)	8.35	17.75	6.83	7.40	5.31	8.35	17.64	41.87	73.15	15.99
Enterprise Value to Free Cash Flow (EV/FCFF)	12.19	32.05	8.77	9.29	5.72	9.00	31.62	0.00	0.00	69.79
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.72	0.73	0.66	0.60	0.56	0.52	0.49	0.45	0.49	0.65
Long-Term Debt to Equity	0.72	0.73	0.66	0.60	0.56	0.52	0.49	0.45	0.49	0.65
Financial Leverage	-2.02	-2.01	-2.02	-1.98	-1.98	-1.78	-1.73	-1.61	-1.73	-1.55
Leverage Ratio	4.29	4.38	4.23	4.07	4.00	3.79	3.71	3.41	3.54	3.50
Compound Leverage Factor	3.93	3.26	3.97	3.82	3.70	3.47	3.48	3.19	3.32	3.19
Debt to Total Capital	41.70%	42.33%	39.84%	37.56%	35.97%	34.09%	32.67%	31.05%	32.84%	39.40%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	41.70%	42.33%	39.84%	37.56%	35.97%	34.09%	32.67%	31.05%	32.84%	39.40%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	58.30%	57.67%	60.16%	62.44%	64.03%	65.91%	67.33%	68.95%	67.16%	60.60%
Debt to EBITDA	1.53	1.61	1.52	1.44	1.42	1.25	1.27	1.27	1.28	1.54
Net Debt to EBITDA	-4.18	-4.13	-4.48	-4.53	-5.05	-4.12	-4.09	-3.97	-3.93	-3.35
Long-Term Debt to EBITDA	1.53	1.61	1.52	1.44	1.42	1.25	1.27	1.27	1.28	1.54
Debt to NOPAT	2.31	2.49	2.32	2.18	2.15	1.86	1.89	1.91	1.90	2.31
Net Debt to NOPAT	-6.31	-6.37	-6.86	-6.88	-7.67	-6.13	-6.09	-5.93	-5.84	-5.01
Long-Term Debt to NOPAT	2.31	2.49	2.32	2.18	2.15	1.86	1.89	1.91	1.90	2.31
Altman Z-Score	4.33	4.49	4.10	4.24	4.03	4.26	4.41	4.34	4.42	4.32
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.45	1.47	1.47	1.52	1.47	1.54	1.49	1.57	1.55	1.62
Quick Ratio	1.39	1.43	1.43	1.48	1.43	1.50	1.44	1.52	1.50	1.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	393	-371	438	482	1,237	606	-295	-979	-1,130	-843
Operating Cash Flow to CapEx	819.35%	-2,120.00%	2,862.50%	1,570.97%	3,650.00%	0.00%	792.59%	-811.11%	2,494.29%	-2,036.36%
Free Cash Flow to Firm to Interest Expense	14.03	-13.73	15.64	17.85	45.81	22.45	-10.91	-34.97	-38.98	-24.80
Operating Cash Flow to Interest Expense	9.07	-7.85	32.71	18.04	35.15	-25.56	7.93	-7.82	30.10	-6.59
Operating Cash Flow Less CapEx to Interest Expense	7.96	-8.22	31.57	16.89	34.19	-25.37	6.93	-8.79	28.90	-6.91
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.62	2.61	2.51	2.49	2.40	2.50	2.48	2.59	2.56	2.66
Accounts Receivable Turnover	15.08	14.28	13.79	14.11	14.21	12.61	12.18	13.32	13.71	12.70
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	32.87	31.40	34.44	35.18	29.57	26.78	31.79	34.47	28.53	26.66
Days Sales Outstanding (DSO)	24.20	25.57	26.47	25.87	25.69	28.96	29.96	27.40	26.63	28.75
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.10	11.62	10.60	10.38	12.34	13.63	11.48	10.59	12.79	13.69
Cash Conversion Cycle (CCC)	13.10	13.94	15.87	15.49	13.34	15.33	18.48	16.81	13.83	15.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-2,907	-2,603	-3,141	-3,246	-3,879	-2,973	-2,525	-1,945	-2,401	-1,854
Invested Capital Turnover	-10.99	-11.31	-10.46	-10.29	-9.80	-12.22	-12.66	-14.41	-12.48	-16.84
Increase / (Decrease) in Invested Capital	-142	446	-96	-153	-972	-370	616	1,301	1,478	1,119
Enterprise Value (EV)	13,216	13,718	9,059	10,695	11,358	13,876	16,933	10,634	13,020	10,298
Market Capitalization	19,164	19,285	15,488	17,562	19,116	21,064	23,951	17,422	20,191	16,648
Book Value per Share	$52.34	$50.75	$56.79	$62.11	$66.54	$72.30	$76.67	$82.65	$81.40	$78.60
Tangible Book Value per Share	$30.60	$26.95	$33.14	$38.99	$41.30	$47.44	$43.79	$50.00	$48.58	$44.72
Total Capital	5,216	5,140	5,465	5,799	6,058	6,395	6,673	7,024	7,102	7,419
Total Debt	2,175	2,176	2,177	2,178	2,179	2,180	2,180	2,181	2,332	2,923
Total Long-Term Debt	2,175	2,176	2,177	2,178	2,179	2,180	2,180	2,181	2,332	2,923
Net Debt	-5,948	-5,567	-6,429	-6,867	-7,758	-7,188	-7,018	-6,788	-7,171	-6,350
Capital Expenditures (CapEx)	31	10	32	31	26	-5.00	27	27	35	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-4,631	-4,276	-4,819	-4,892	-5,700	-4,733	-4,783	-4,206	-4,670	-4,110
Debt-free Net Working Capital (DFNWC)	3,250	3,229	3,545	3,904	3,976	4,374	4,154	4,495	4,544	4,877
Net Working Capital (NWC)	3,250	3,229	3,545	3,904	3,976	4,374	4,154	4,495	4,544	4,877
Net Nonoperating Expense (NNE)	21	19	21	20	20	20	20	21	22	25
Net Nonoperating Obligations (NNO)	-5,948	-5,567	-6,429	-6,867	-7,758	-7,188	-7,018	-6,788	-7,171	-6,350
Total Depreciation and Amortization (D&A)	45	47	44	42	42	43	45	46	47	48
Debt-free, Cash-free Net Working Capital to Revenue	-14.86%	-13.37%	-14.90%	-14.99%	-17.14%	-13.89%	-13.34%	-11.24%	-11.91%	-10.11%
Debt-free Net Working Capital to Revenue	10.43%	10.10%	10.96%	11.97%	11.96%	12.84%	11.59%	12.02%	11.59%	12.00%
Net Working Capital to Revenue	10.43%	10.10%	10.96%	11.97%	11.96%	12.84%	11.59%	12.02%	11.59%	12.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.00	$0.98	$5.58	$5.37	$4.24	$3.72	$5.21	$5.18	$5.67	$4.46
Adjusted Weighted Average Basic Shares Outstanding	58.40M	57.80M	58.30M	58.30M	58.30M	57.70M	58.60M	58.60M	57.20M	57.40M
Adjusted Diluted Earnings per Share	$3.95	$0.96	$5.52	$5.35	$4.21	$3.69	$5.17	$5.17	$5.65	$4.43
Adjusted Weighted Average Diluted Shares Outstanding	58.40M	58.50M	58.30M	58.30M	58.30M	58.10M	58.60M	58.60M	57.20M	57.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.40M	57.90M	58.30M	58.30M	58.30M	58.40M	58.60M	58.60M	57.20M	55.50M
Normalized Net Operating Profit after Tax (NOPAT)	251	75	342	329	265	236	321	322	348	276
Normalized NOPAT Margin	3.17%	0.92%	4.20%	3.95%	3.10%	2.61%	3.24%	3.26%	3.36%	2.63%
Pre Tax Income Margin	3.87%	0.95%	5.24%	5.00%	3.88%	3.19%	4.02%	4.11%	4.24%	3.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.96	3.89	16.25	16.41	13.30	11.70	15.78	15.50	16.10	11.18
NOPAT to Interest Expense	8.96	2.79	12.22	12.19	9.81	8.75	11.90	11.49	11.99	8.11
EBIT Less CapEx to Interest Expense	10.86	3.52	15.11	15.26	12.33	11.89	14.78	14.54	14.90	10.85
NOPAT Less CapEx to Interest Expense	7.86	2.42	11.07	11.04	8.85	8.93	10.90	10.53	10.78	7.78
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	23.84%	50.51%	0.00%	0.00%	21.48%	0.00%	0.00%	0.00%	43.71%	84.82%

Frequently Asked Questions About Molina Healthcare's Financials

When does Molina Healthcare's financial year end?

According to the most recent income statement we have on file, Molina Healthcare's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Molina Healthcare's net income changed over the last 9 years?

Molina Healthcare's net income appears to be on an upward trend, with a most recent value of $1.18 billion in 2024, rising from $143 million in 2015. The previous period was $1.09 billion in 2023.

What is Molina Healthcare's operating income?

Molina Healthcare's total operating income in 2024 was $1.71 billion, based on the following breakdown:

Total Gross Profit: $6.22 billion
Total Operating Expenses: $4.52 billion

How has Molina Healthcare revenue changed over the last 9 years?

Over the last 9 years, Molina Healthcare's total revenue changed from $14.18 billion in 2015 to $40.65 billion in 2024, a change of 186.7%.

How much debt does Molina Healthcare have?

Molina Healthcare's total liabilities were at $11.13 billion at the end of 2024, a 4.3% increase from 2023, and a 121.8% increase since 2015.

How much cash does Molina Healthcare have?

In the past 9 years, Molina Healthcare's cash and equivalents has ranged from $2.33 billion in 2015 to $4.85 billion in 2023, and is currently $4.66 billion as of their latest financial filing in 2024.

How has Molina Healthcare's book value per share changed over the last 9 years?

Over the last 9 years, Molina Healthcare's book value per share changed from 27.76 in 2015 to 78.60 in 2024, a change of 183.1%.

Remove Ads

Related Companies

This page (NYSE:MOH) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Molina Healthcare (MOH) Financials

Frequently Asked Questions About Molina Healthcare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Molina Healthcare (MOH) Financials

Annual Income Statements for Molina Healthcare

Quarterly Income Statements for Molina Healthcare

Annual Cash Flow Statements for Molina Healthcare

Quarterly Cash Flow Statements for Molina Healthcare

Annual Balance Sheets for Molina Healthcare

Quarterly Balance Sheets for Molina Healthcare

Annual Metrics and Ratios for Molina Healthcare

Quarterly Metrics and Ratios for Molina Healthcare

Frequently Asked Questions About Molina Healthcare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools